Open AccessSafety of egg membrane hydrolysate as a novel food pursuant to Regulation ( EU ) 2015/2283
Author(s) -
Turck Dominique,
Bresson JeanLouis,
Burlingame Barbara,
Dean Tara,
FairweatherTait Susan,
Hein Marina,
HirschErnst Karen Ildico,
Mangelsdorf Inge,
McArdle Harry J,
Naska Androniki,
NeuhäuserBerthold Monika,
Nowicka Grażyna,
Pentieva Kristina,
Sanz Yolanda,
Siani Alfonso,
Sjödin Anders,
Stern Martin,
Tomé Daniel,
Vinceti Marco,
Willatts Peter,
Engel KarlHeinz,
Marchelli Rosangela,
Pöting Annette,
Schlatter Josef Rudolf,
Ackerl Reinhard,
Loveren Henk
Publication year - 2018
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2018.5363
Subject(s) - hydrolysate , european commission , food science , population , food safety , microbiology and biotechnology , european union , business , chemistry , environmental health , biology , medicine , biochemistry , hydrolysis , economic policy
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies ( NDA ) was asked to deliver a scientific opinion on egg membrane hydrolysate as a novel food ( NF ) pursuant to Regulation ( EU ) 2015/2283. The NF is a water‐soluble hydrolysate of egg membrane, produced by alkaline treatment of the thin layer lining the shells of chicken eggs. The main constituents of the NF are elastin, collagen and glycosaminoglycans. The information provided on the production process, batch‐to‐batch variability, composition and specifications of the NF is sufficient and does not raise safety concerns. The NF is proposed to be used as a food supplement for adults, at a maximum daily amount of 450 mg. The consumption of the NF is not nutritionally disadvantageous. One human study, which was not designed for safety but included a number of endpoints pertaining to safety, did not raise safety concerns. The Panel considers that taking into account the information provided and considering the nature, the source and the production process of the NF , there are no safety concerns for the NF at the proposed conditions of use. The Panel concludes that the NF , egg membrane hydrolysate, is safe as a food supplement at a dose of 450 mg/day. The target population for the NF is the general adult population.